Capturing BRCA1/2 Mutational Status in Women With High Grade Serous Ovarian Cancer and Impact on Clinical Outcome.
Sponsor: University Health Network, Toronto
Terminated
This study did not collect sufficient data for primary endpoint analysis.
Other terminated trials from University Health Network, Toronto
- ACL Injury · Apr 2026
- Endometrial Carcinoma · Phase PHASE2/PHASE3 · May 2025
- Intrahepatic Cholangiocarcinoma · Phase PHASE2 · Dec 2024
- Central Venous Catheter Thrombosis · Phase PHASE3 · Oct 2024
- Hepatocellular Carcinoma · Phase PHASE2 · Feb 2024
See all terminations from University Health Network, Toronto
Listed as NCT02341118, this observational or N/A phase trial focuses on Ovarian Cancer and remains terminated or withdrawn. Sponsored by University Health Network, Toronto, it has been updated 11 times since 2014, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Aug 2023 — Jul 2024 [monthly]
Terminated
Status: Active Not Recruiting → Terminated
-
Oct 2021 — Aug 2023 [monthly]
Active Not Recruiting
-
Apr 2021 — Oct 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
▶ Show 6 earlier versions
-
Jan 2021 — Apr 2021 [monthly]
Recruiting
-
Jan 2020 — Jan 2021 [monthly]
Recruiting
-
Nov 2018 — Jan 2020 [monthly]
Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Health Network, Toronto
For direct contact, visit the study record on ClinicalTrials.gov .